TWP
GILD icon

Tempus Wealth Planning’s Gilead Sciences GILD Stock Holding History

Tempus Wealth Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,000
Closed -$7K – 83
2020
Q3 		$7K Buy
+5,000
New +$347K 0.01% 72

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Tempus Wealth Planning's GILD Position: Q2 2026 in Review

Tempus Wealth Planning increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $28.5K and bringing the position to 2,116 shares worth $267K. The position accounts for 0.05% of the portfolio, ranked #241.

Tempus Wealth Planning first reported a position in GILD in Q3 2020 and has held it in 4 quarters since. 602 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Tempus Wealth Planning held 2,116 shares of Gilead Sciences worth $267K as of Q2 2026.
  • Tempus Wealth Planning bought 216 Gilead Sciences shares in Q2 2026, an estimated $28.5K.
  • Gilead Sciences made up 0.05% of Tempus Wealth Planning's portfolio in Q2 2026, its #241 holding.
  • Tempus Wealth Planning first reported a position in Gilead Sciences in Q3 2020 and has held it in 4 quarters since.
  • 602 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.